Susan M Harrington Selected Research

Susan M Harrington Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 02/2012
5	Melanoma (Melanoma, Malignant) 02/2024 - 06/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 06/2015
2	Inflammation (Inflammations) 11/2019 - 11/2005
2	Infections 11/2010 - 05/2006
1	Adenocarcinoma 01/2022
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Triple Negative Breast Neoplasms 12/2018
1	Abscess 08/2016
1	Tuberculosis (Tuberculoses) 08/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013
1	Persistent Infection 10/2012
1	Sepsis (Septicemia) 06/2012
1	Zygomycosis (Phycomycosis) 11/2008
1	Job Syndrome (Hyper-IgE Syndrome) 06/2006
1	Uveitis 06/2006

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2016
2	atezolizumabIBA 02/2024 - 09/2021
2	AcidsIBA 11/2019 - 08/2016
2	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 08/2015
2	p38 Mitogen-Activated Protein KinasesIBA 12/2018 - 11/2016
2	B7-H1 AntigenIBA 01/2018 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 06/2013 - 11/2008
1	VemurafenibIBA 02/2024
1	cobimetinibIBA 02/2024
1	avelumabIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	CalciumIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Zirconium-89IBA 09/2021
1	LigandsIBA 01/2019
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 12/2018
1	Immune Checkpoint ProteinsIBA 12/2018
1	Monoclonal AntibodiesIBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	DNA-Activated Protein KinaseIBA 12/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	PerforinIBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Blocking AntibodiesIBA 11/2016
1	AntibodiesIBA 11/2016
1	Interleukin-12 (IL 12)IBA 10/2016
1	Toll-Like Receptor AgonistsIBA 10/2016
1	CatalaseIBA 08/2016
1	Coloring Agents (Dyes)IBA 08/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015
1	HLA-DR Antigens (HLA-DR)IBA 09/2015
1	Cancer VaccinesIBA 08/2014
1	IntegrinsIBA 06/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Programmed Cell Death 1 ReceptorIBA 10/2012
1	Claudin-1IBA 11/2010
1	Tight Junction ProteinsIBA 11/2010
1	OccludinIBA 11/2010
1	Gentamicins (Gentamicin)FDA LinkGeneric 11/2010
1	28S Ribosomal RNAIBA 11/2008
1	23S Ribosomal RNAIBA 06/2006
1	Linezolid (Zyvox)FDA Link 06/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2006
1	Anti-Infective Agents (Microbicides)IBA 05/2006
1	A-factor (Streptomyces)IBA 11/2005
1	Interleukin-8 (Interleukin 8)IBA 11/2005
1	FlagellinIBA 11/2005

Therapy/Procedure

14	Therapeutics 02/2024 - 05/2006
8	Immunotherapy 02/2024 - 02/2012
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Nephrectomy 01/2023
1	Neoadjuvant Therapy 01/2022
1	Radiotherapy 06/2015
1	Catheters 06/2012